Top

Published in:

01-02-2000 | ORIGINAL ARTICLE

Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma

Authors: Jesper Max Tordsson, Lennart Göran Ohlsson, Lars Bertil Abrahmsén, Pia Jasmine Karlström, Peter Anders Lando, Thomas Nils Brodin

Published in: Cancer Immunology, Immunotherapy | Issue 12/2000

Title: Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma
Authors: Jesper Max Tordsson
Lennart Göran Ohlsson
Lars Bertil Abrahmsén
Pia Jasmine Karlström
Peter Anders Lando
Thomas Nils Brodin
Publication date: 01-02-2000
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 12/2000
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s002620050018

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 12/2000

Observed localization of the long-term cultured rat adherent natural killer cells in mammary tumor tissues

Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression

1999 REVIEWERS

Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens

Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer